Recruiting at 1 site Phase 1, Phase 2 PARKINSON DISEASE (Disorder)

Clinical trial for PARKINSON DISEASE (Disorder)

Official title Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

ClinicalTrials.gov ID: NCT07182058

What this study is testing

What it's testing
The study wants to find out whether gentle electrical signals applied to the scalp can reduce tremor, stiffness, and slowness of movement in Parkinson's patients, and whether any benefit lasts after treatment stops.
Who it's for
Adults aged 18‑80 with Parkinson's disease who are on stable medication and have reliable internet access.
What's involved
Participants will wear a small headset that sends mild electrical signals for 13 minutes each weekday for 3 weeks, record videos of their movements at home, and attend virtual visits and online assessments.
Time commitment
The trial lasts 6 weeks total, with daily at‑home sessions for the first 3 weeks and virtual check‑ins throughout.
  • Phase 2: a mid-size study of how well it works
  • Time commitment: about 6 weeks
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 80

You may be able to join if

  • Adults 18-80 years with confirmed diagnosis of Parkinson's Disease
  • Hoehn \& Yahr stages 1-4
  • Stable medication regimen for 4+ weeks prior to enrollment
  • Reliable internet access and telehealth capability
  • Ability to provide informed consent

You likely can't join if

  • Metallic head/neck implants (excluding dental fillings)
  • Pregnancy or nursing status
  • Severe skin conditions at electrode placement sites
  • History of epilepsy or seizures (unless technology specifically indicated)
  • Recent stroke or traumatic brain injury (within 6 months)
  • Severe cognitive impairment preventing treatment understanding
See the full eligibility criteria
Who can join
  • Adults 18-80 years with confirmed diagnosis of Parkinson's Disease
  • Hoehn \& Yahr stages 1-4
  • Stable medication regimen for 4+ weeks prior to enrollment
  • Reliable internet access and telehealth capability
  • Ability to provide informed consent
  • Willingness to comply with treatment protocols and follow-up procedures
What rules you out
  • Metallic head/neck implants (excluding dental fillings)
  • Pregnancy or nursing status
  • Severe skin conditions at electrode placement sites
  • History of epilepsy or seizures (unless technology specifically indicated)
  • Recent stroke or traumatic brain injury (within 6 months)
  • Severe cognitive impairment preventing treatment understanding
  • Any neurological disorders contraindicating transcranial electrical stimulation
  • Current participation in other clinical trials
  • Inability to commit to full treatment and follow-up schedule

The study team makes the final eligibility decision.

Where it is enrolling

  • Cleveland, Ohio, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.